Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,577
  • Shares Outstanding, K 15,607
  • Annual Sales, $ 13,270 K
  • Annual Income, $ -5,150 K
  • 60-Month Beta 1.26
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book 0.29
Trade SNOA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.78
  • Most Recent Earnings $-0.06 on 02/08/24
  • Latest Earnings Date 02/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +434,447.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1311 +41.11%
on 03/20/24
0.1860 -0.54%
on 03/28/24
+0.0418 (+29.19%)
since 02/28/24
3-Month
0.1311 +41.11%
on 03/20/24
0.3178 -41.79%
on 01/31/24
-0.0128 (-6.47%)
since 12/28/23
52-Week
0.1159 +59.62%
on 11/10/23
1.5200 -87.83%
on 06/09/23
-0.9650 (-83.91%)
since 03/28/23

Most Recent Stories

More News
Investors Chat: Instacart IPO

Instacart is profitable and growing. Is that enough to spark investor interest?

LYV : 105.92 (-0.83%)
WMT : 60.43 (-0.48%)
MCD : 283.00 (+0.35%)
DIS : 122.38 (+1.16%)
CPB : 44.61 (+1.23%)
UBER : 77.18 (-1.19%)
DASH : 139.05 (+0.12%)
NFLX : 602.56 (-1.79%)
AMZN : 180.95 (+0.62%)
PEP : 175.13 (+0.90%)
SNOA : 0.1719 (+4.12%)
Augmented Reality Devices: Apple vs. Meta Platforms

Plus, how to plan for a healthier retirement.

AAPL : 170.88 (-1.40%)
TMUS : 162.98 (+0.60%)
META : 489.81 (-0.82%)
SNOA : 0.1719 (+4.12%)
COIN : 265.39 (+3.39%)
VZ : 41.70 (+0.39%)
T : 17.55 (+0.17%)
UBER : 77.18 (-1.19%)
Sonoma Pharmaceuticals (NASDAQ: SNOA) and EMC Pharma Receives DAPA Registration for Microcyn Rx Products from U.S. Department of Defense

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is a global healthcare company that is focused on the research, development and production of

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results

WOODSTOCK, GA / ACCESSWIRE / July 13, 2022 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous...

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1719 (+4.12%)
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA : 0.1719 (+4.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus...

See More

Key Turning Points

3rd Resistance Point 0.2036
2nd Resistance Point 0.1901
1st Resistance Point 0.1776
Last Price 0.1719
1st Support Level 0.1516
2nd Support Level 0.1381
3rd Support Level 0.1256

See More

52-Week High 1.5200
Fibonacci 61.8% 0.9836
Fibonacci 50% 0.8180
Fibonacci 38.2% 0.6523
Last Price 0.1719
52-Week Low 0.1159

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar